UBS Group
BRAI

UBS Group’s Braiin Ltd BRAI Stock Holding History

UBS Group’s Portfolio BRAI Stock Details BRAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9K Sell
2,114
-268
-11% -$2.06K ﹤0.01% 8421
2026
Q1 		$16.6K Buy
+2,382
New +$18.2K ﹤0.01% 8068

Other funds holding BRAI

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group's BRAI Position: Q2 2026 in Review

UBS Group reduced its Braiin Ltd (BRAI) stake by 11% in Q2 2026, selling an estimated $2.06K and leaving 2,114 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #8421.

UBS Group first reported a position in BRAI in Q1 2026 and has held it in 2 quarters since. The position peaked at $16.6K in Q1 2026. 7 funds tracked by Wall St. Rank hold BRAI as of Q2 2026.

  • UBS Group held 2,114 shares of Braiin Ltd worth $12.9K as of Q2 2026.
  • UBS Group sold 268 Braiin Ltd shares in Q2 2026, an estimated $2.06K.
  • Braiin Ltd made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8421 holding.
  • UBS Group first reported a position in Braiin Ltd in Q1 2026 and has held it in 2 quarters since.
  • UBS Group's Braiin Ltd position peaked at $16.6K in Q1 2026.
  • 7 funds tracked by Wall St. Rank held Braiin Ltd as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.